Referências
Principais artigos
World Health Organization. Community management of opioid overdose. Geneva: World Health Organization; 2014.Texto completo Resumo
Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Evidence-based strategies for preventing opioid overdose: what’s working in the United States. 22 October 2020 [internet publication].Texto completo
Dezfulian C, Orkin AM, Maron BA, et al. Opioid-associated out-of-hospital cardiac arrest: distinctive clinical features and implications for health care and public responses: a scientific statement from the American Heart Association. Circulation. 2021 Apr 20;143(16):e836-70.Texto completo Resumo
Williams K, Lang ES, Panchal AR, et al. Evidence-based guidelines for EMS administration of naloxone. Prehosp Emerg Care. 2019 Nov-Dec;23(6):749-63.Texto completo Resumo
Artigos de referência
1. World Health Organization. Opioid overdose. 4 August 2021 [internet publication].Texto completo
2. Office for National Statistics. Census 2021 - Deaths related to drug poisoning in England and Wales: 2020 registrations. 3 August 2021 [internet publication].Texto completo
3. Centers for Disease Control and Prevention. Opioid overdose: understanding the epidemic. 17 March 2021 [internet publication].Texto completo
4. Drug Abuse Warning Network. The DAWN report: highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. February 2013 [internet publication].Texto completo
5. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):618-27. Resumo
6. Seth P, Scholl L, Rudd RA, et al. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-58.Texto completo Resumo
7. Centers for Disease Control and Prevention. Rising numbers of deaths involving fentanyl and fentanyl analogs, including carfentanil, and increased usage and mixing with non-opioids. HAN no. 413. July 2018 [internet publication].Texto completo
8. Kariisa M, Patel P, Smith H, et al. Notes from the Field: xylazine detection and involvement in drug overdose deaths - United States, 2019. MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1300-2.Texto completo Resumo
9. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison - a high risk of death for former inmates. N Engl J Med. 2007 Jan 11;356(2):157-65. Resumo
10. Anoro M, Ilundain E, Rodriguez R, et al. Factors related to experiencing respiratory failure in cases of opiate overdose for which care was provided in an open setting. Barcelona, Spain. Rev Esp Salud Publica. Sep-Oct 2004;78(5):601-8.Texto completo Resumo
11. Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89-96. Resumo
12. Substance Abuse and Mental Health Services Administration (SAMHSA). Opioid overdose prevention toolkit. June 2018 [internet publication].Texto completo
13. World Health Organization. Community management of opioid overdose. Geneva: World Health Organization; 2014.Texto completo Resumo
14. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Evidence-based strategies for preventing opioid overdose: what’s working in the United States. 22 October 2020 [internet publication].Texto completo
15. US Department of Health and Human Services. Naloxone: the opioid reversal drug that saves lives. How healthcare providers and patients can better utilize this life-saving drug. December 2018 [internet publication].Texto completo
16. Public Health England. Widening the availability of naloxone. 18 February 2019 [internet publication].Texto completo
17. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016 Mar 18;65(1):1-49.Texto completo Resumo
18. Babu KM, Brent J, Juurlink DN. Prevention of opioid overdose. N Engl J Med. 2019 Jun 6;380(23):2246-55.Texto completo Resumo
19. Sharma V, Simpson SH, Samanani S, et al. Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study. BMJ Open. 2020 Nov 20;10(11):e038692.Texto completo Resumo
20. Chang AK, Bijur PE, Esses D, et al. Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department: a randomized clinical trial. JAMA. 2017 Nov 7;318(17):1661-7. Resumo
21. Medicines and Healthcare products Regulatory Agency. Serious and fatal overdose of fentanyl patches. 11 December 2014 [internet publication].Texto completo
22. US Food and Drug Administration. Accidental exposures to fentanyl patches continue to be deadly to children. 21 July 2021 [internet publication].Texto completo
23. Dezfulian C, Orkin AM, Maron BA, et al. Opioid-associated out-of-hospital cardiac arrest: distinctive clinical features and implications for health care and public responses: a scientific statement from the American Heart Association. Circulation. 2021 Apr 20;143(16):e836-70.Texto completo Resumo
24. Resuscitation Council UK. 2021 resuscitation guidelines. 2021 [internet publication].Texto completo
25. Hoffman JR, Schriger DL, Luo JS. The empiric use of naloxone in patients with altered mental status: a reappraisal. Ann Emerg Med. 1991 Mar;20(3):246-52. Resumo
26. Hierholzer J, Cordes M, Tantow H, et al. Drug smuggling by ingested cocaine-filled packages: conventional x-ray and ultrasound. Abdom Imaging. 1995 Jul-Aug;20(4):333-8. Resumo
27. McCarron MM, Wood JD. The cocaine 'body packer' syndrome. Diagnosis and treatment. JAMA. 1983 Sep 16;250(11):1417-20. Resumo
28. Whipple JK, Quebbeman EJ, Lewis KS, et al. Difficulties in diagnosing narcotic overdoses in hospitalized patients. Ann Pharmacother. 1994 Apr;28(4):446-50. Resumo
29. Williams K, Lang ES, Panchal AR, et al. Evidence-based guidelines for EMS administration of naloxone. Prehosp Emerg Care. 2019 Nov-Dec;23(6):749-63.Texto completo Resumo
30. American Heart Association. 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020 Oct 20;142(16_suppl_2):S366-604.Texto completo
31. Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012 Jul 12;367(2):146-55.Texto completo Resumo
32. Mills CA, Flacke JW, Flacke WE, et al. Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine. Can J Anaesth. 1990 Mar;37(2):238-44. Resumo
33. Mills CA, Flacke JW, Miller JD, et al. Cardiovascular effects of fentanyl reversal by naloxone at varying arterial carbon dioxide tensions in dogs. Anesth Analg. 1988 Aug;67(8):730-6. Resumo
34. Thadani PV. NIDA conference report on cardiopulmonary complications of "crack" cocaine use. Clinical manifestations and pathophysiology. Chest. 1996 Oct;110(4):1072-6. Resumo
35. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1334-49. Resumo
36. Kerr D, Kelly AM, Dietze P, et al. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009 Dec;104(12):2067-74. Resumo
37. Chou R, Korthuis PT, McCarty D, et al. Management of suspected opioid overdose with naloxone in out-of-hospital settings: a systematic review. Ann Intern Med. 2017 Dec 19;167(12):867-75.Texto completo Resumo
38. Dietze P, Jauncey M, Salmon A, et al. Effect of intranasal vs intramuscular naloxone on opioid overdose: a randomized clinical trial. JAMA Netw Open. 2019 Nov 1;2(11):e1914977.Texto completo Resumo
39. Sutter ME, Gerona RR, Davis MT, et al. Fatal fentanyl: one pill can kill. Acad Emerg Med. 2017 Jan;24(1):106-13.Texto completo Resumo
40. Rogers JS, Rehrer SJ, Hoot NR. Acetylfentanyl: an emerging drug of abuse. J Emerg Med. 2016 Mar;50(3):433-6. Resumo
41. Howland MAH. Antidotes in depth opioid antagonists. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicological emergencies. 8th ed. New York, NY: McGraw-Hill; 2006:614-7.
42. van Dorp E, Yassen A, Sarton E, et al. Naloxone reversal of buprenorphine-induced respiratory depression. Anesthesiology. 2006 Jul;105(1):51-7. Resumo
43. Gal TJ. Naloxone reversal of buprenorphine-induced respiratory depression. Clin Pharmacol Ther. 1989 Jan;45(1):66-71. Resumo
44. Wong S, Ordean A, Kahan M; Working Group on Problematic Substance Use in Pregnancy. Society of Obstetricians and Gynaecologists of Canada clinical practice guideline: substance use in pregnancy. April 2011 [internet publication].Texto completo
45. O'Driscoll BR, Howard LS, Earis J, et al; British Thoracic Society Emergency Oxygen Guideline Group; BTS Emergency Oxygen Guideline Development Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017 Jun;72(suppl 1):ii1-ii90.Texto completo Resumo
46. Purdue Pharma. FDA approves nalmefene HCl injection, 2mg/2mL (1mg/1mL) for the treatment of known or suspected opioid overdose with natural or synthetic opioids. 23 February 2022 [internet publication].Texto completo
47. Olfson M, Crystal S, Wall M, et al. Causes of death after nonfatal opioid overdose. JAMA Psychiatry. 2018 Aug 1;75(8):820-7.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal